FDA Inspection 1304002 — Dhwaniben Ranchhodbhai Makwana
The FDA completed an inspection of Dhwaniben Ranchhodbhai Makwana on Jan 23, 2026 in Ahmedabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 23, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ahmedabad (India)
Additional details
Clinical BA/BE